iSpecimen Inc. 8-K

What Happened
iSpecimen Inc. announced (8‑K filed Jan 5, 2026) that its 2025 Annual Meeting of Stockholders, convened on December 31, 2025, was adjourned because a quorum was not achieved. The adjournment was taken to allow additional time for stockholders to vote on the proposals in the Company’s definitive proxy statement filed with the SEC on November 21, 2025. The Company intends to reconvene the Annual Meeting on January 23, 2026. The record date for the meeting remains November 3, 2025.

Key Details

• Annual Meeting convened and adjourned on December 31, 2025 due to lack of quorum.
• Company intends to reconvene the meeting on January 23, 2026.
• Record date for voting remains November 3, 2025.
• Related proxy statement was filed with the SEC on November 21, 2025.

Why It Matters
An adjournment for lack of quorum means the proposed corporate actions (e.g., director elections or other proposals included in the proxy) were not decided and will be delayed until the reconvened meeting. For investors, only holders of record as of the November 3, 2025 record date are eligible to vote, so those shareholders should review the proxy materials and ensure their votes are submitted ahead of the reconvened meeting. The adjournment itself does not change the substance of the proposals, but it does delay final outcomes and any governance changes tied to the meeting.